441 filings
Page 14 of 23
8-K
inhm6q0q6 mgalzv
19 Sep 16
Positive Phase 3 Data Results
12:00am
8-K
lhmq tdf6bqk6j
15 Sep 16
Other Events
12:00am
8-K
xtiidet1uc7kmwlf1
15 Aug 16
Regulation FD Disclosure
12:00am
8-K
676od3 hsmnrt2
2 Aug 16
Tim Morris; AcelRx Pharmaceuticals, Inc.; CFO and Head of Business Development
12:00am
8-K
f2qibeqg kj0w
8 Jul 16
Regulation FD Disclosure
12:00am
8-K
xiov9h8pp3l
22 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
sffi7qfo rgvuj089hdm
21 Jun 16
Entry into a Material Definitive Agreement
12:00am
424B5
rsjx y8dpr
21 Jun 16
Prospectus supplement for primary offering
12:00am
CT ORDER
pedjg3olbdjv
16 May 16
Confidential treatment order
12:00am
8-K
8ulnpeo g8m
4 May 16
Timothy Morris; AcelRx Pharmaceuticals, Inc.; CFO and Head of Business Development
12:00am
DEFA14A
u4qhxqbx9r
28 Apr 16
Additional proxy soliciting materials
12:00am
8-K
o8xfb7n
31 Mar 16
Other Events
12:00am
8-K
fuphdvh 4wvqi8lyl
30 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
fg8j9a4g5p h2yb3dv1
14 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
6yz09hjyvqhspwhl m3
9 Mar 16
Tim Morris; AcelRx Pharmaceuticals, Inc.; CFO, Head of Business Development
12:00am
S-8
qu91ksw1c83
7 Mar 16
Registration of securities for employees
12:00am